Bridgeway Capital Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-13,300
| Closed | -$92K | – | 1333 |
|
|
2020
Q3 | $92K | Sell |
13,300
-30,000
| -69% | -$208K | ﹤0.01% | 1263 |
|
|
2020
Q2 | $532K | Sell |
43,300
-10,000
| -19% | -$123K | 0.01% | 838 |
|
|
2020
Q1 | $154K | Sell |
53,300
-55,400
| -51% | -$160K | ﹤0.01% | 1121 |
|
|
2019
Q4 | $412K | Buy |
+108,700
| New | +$412K | 0.01% | 1051 |
|
|
2019
Q2 | – | Sell |
-201,400
| Closed | -$318K | – | 1354 |
|
|
2019
Q1 | $318K | Sell |
201,400
-50,000
| -20% | -$78.9K | ﹤0.01% | 1137 |
|
|
2018
Q4 | $292K | Buy |
251,400
+76,400
| +44% | +$88.7K | ﹤0.01% | 1133 |
|
|
2018
Q3 | $648K | Buy |
175,000
+75,000
| +75% | +$278K | 0.01% | 1068 |
|
|
2018
Q2 | $306K | Buy |
+100,000
| New | +$306K | ﹤0.01% | 1247 |
|